Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.6 Million CAD | 108.9% |
| 2022 | 6.98 Million CAD | 229.59% |
| 2021 | 2.12 Million CAD | 29.29% |
| 2020 | 1.64 Million CAD | 5159.05% |
| 2019 | 31.19 Thousand CAD | -97.87% |
| 2018 | 1.46 Million CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 14.4 Million CAD | -2.71% |
| 2024 Q1 | 14.8 Million CAD | 1.39% |
| 2023 Q1 | 8.47 Million CAD | 21.32% |
| 2023 FY | 14.6 Million CAD | 108.9% |
| 2023 Q2 | 8.1 Million USD | -4.45% |
| 2023 Q3 | 8.36 Million USD | 3.21% |
| 2023 Q4 | 14.6 Million CAD | 74.6% |
| 2022 FY | 6.98 Million CAD | 229.59% |
| 2022 Q4 | 6.98 Million CAD | 26.85% |
| 2022 Q3 | 5.51 Million CAD | -5.51% |
| 2022 Q2 | 5.83 Million CAD | 2.11% |
| 2022 Q1 | 5.71 Million CAD | 169.3% |
| 2021 Q1 | 1.46 Million CAD | 1541.1% |
| 2021 FY | 2.12 Million CAD | 29.29% |
| 2021 Q4 | 2.12 Million CAD | 26.11% |
| 2021 Q3 | 1.68 Million CAD | 31.07% |
| 2021 Q2 | 1.28 Million CAD | -12.18% |
| 2020 FY | 1.64 Million CAD | 5159.05% |
| 2020 Q3 | 1.45 Million CAD | 6.71% |
| 2020 Q2 | 1.36 Million CAD | 0.0% |
| 2020 Q1 | - CAD | -100.0% |
| 2020 Q4 | 89.02 Thousand CAD | -93.87% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q4 | 1.42 Million CAD | 0.0% |
| 2019 FY | 31.19 Thousand CAD | -97.87% |
| 2018 FY | 1.46 Million CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -304.683% |
| Arrayit Corporation | 7.49 Million USD | -94.768% |
| Atlantic International Corp. | 3.82 Million USD | -281.363% |
| Biocept, Inc. | 22.01 Million USD | 33.671% |
| Bioqual, Inc. | 18.93 Million USD | 22.901% |
| CardioGenics Holdings Inc | 1.79 Million USD | -713.458% |
| DermTech, Inc. | 64.75 Million USD | 77.452% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 98.013% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -17.883% |
| iMD Companies, Inc. | 1.67 Million USD | -772.106% |
| IDenta Corp. | 1.01 Million USD | -1341.132% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 48.145% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -4800.518% |
| InVitro International | 78.99 Thousand USD | -18384.549% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 25.992% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -11192.563% |
| Medical Imaging Corp. | 9.51 Million USD | -53.418% |
| NovelStem International Corp. | 4.2 Million USD | -247.139% |
| Optigenex Inc. | 9.57 Million USD | -52.56% |
| PharmChem, Inc. | 558.64 Thousand USD | -2513.626% |
| Proteome Sciences plc | 18.48 Million USD | 21.029% |
| Response Genetics, Inc | 15.86 Million USD | 7.979% |
| Rennova Health, Inc. | 49.66 Million USD | 70.603% |
| RushNet, Inc. | 6.23 Million USD | -134.027% |
| ScreenPro Security Inc. | 1.6 Million USD | -812.224% |
| Stella Diagnostics Inc. | 18 Million USD | 18.908% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -77.974% |
| Todos Medical Ltd. | 50.15 Million USD | 70.89% |